ESPR - CIK 0001434868
Esperion Therapeutics, Inc. has filed 885 documents with the SEC between 2008 and 2026. The most frequent type is insider trade (331 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Passive ownership stake (update) | SC 13G/A | 2024-01-03 | - |
| Quarterly report | 10-Q | 2023-11-07 | 2023-09-30 |
| Major company event | 8-K | 2023-11-07 | 2023-11-07 |
| Passive ownership stake | SC 13G | 2023-10-05 | - |
| Insider trade | 4 | 2023-09-21 | 2023-09-20 |
| Insider sale notice | 144 | 2023-09-20 | - |
| Passive ownership stake | SC 13G | 2023-08-29 | - |
| Passive ownership stake | SC 13G | 2023-08-28 | - |
| Employee stock plan | S-8 | 2023-08-24 | - |
| Insider trade | 4 | 2023-08-21 | 2023-08-18 |
| Insider sale notice | 144 | 2023-08-18 | - |
| Insider trade | 4 | 2023-08-09 | 2023-08-08 |
| Employee stock plan | S-8 | 2023-08-01 | - |
| Quarterly report | 10-Q | 2023-08-01 | 2023-06-30 |
| Major company event | 8-K | 2023-08-01 | 2023-08-01 |
| Insider trade | 4 | 2023-07-20 | 2023-07-19 |
| Insider sale notice | 144 | 2023-07-19 | - |
| Major company event | 8-K | 2023-06-26 | 2023-06-24 |
| Insider trade | 4 | 2023-06-22 | 2023-06-21 |
| Insider sale notice | 144 | 2023-06-21 | - |
| Insider trade | 4 | 2023-06-16 | 2023-06-15 |
| Insider trade | 4 | 2023-06-16 | 2023-06-15 |
| Insider trade | 4 | 2023-06-16 | 2023-06-15 |
| Insider trade | 4 | 2023-06-16 | 2023-06-15 |
| Insider trade | 4 | 2023-06-16 | 2023-06-15 |
| Insider trade | 4 | 2023-06-16 | 2023-06-15 |
| Insider trade | 4 | 2023-06-16 | 2023-06-15 |
| Insider trade | 4 | 2023-06-16 | 2023-06-15 |
| Major company event | 8-K | 2023-06-15 | 2023-06-15 |
| Passive ownership stake (update) | SC 13G/A | 2023-06-08 | - |
| Proxy materials | DEFA14A | 2023-05-25 | - |
| Insider trade | 4 | 2023-05-18 | 2023-05-17 |
| Insider sale notice | 144 | 2023-05-17 | - |
| Insider trade | 4 | 2023-05-11 | 2023-05-10 |
| Insider trade | 4 | 2023-05-11 | 2023-05-10 |
| Insider trade | 4 | 2023-05-10 | 2023-05-09 |
| Quarterly report | 10-Q | 2023-05-09 | 2023-03-31 |
| Major company event | 8-K | 2023-05-09 | 2023-05-09 |
| Major company event | 8-K | 2023-05-04 | 2023-05-04 |
| Insider trade | 4 | 2023-04-20 | 2023-04-19 |
| Insider trade | 4 | 2023-04-20 | 2023-04-19 |
| Insider trade | 4 | 2023-04-20 | 2023-04-19 |
| 144/A | - | 2023-04-19 | - |
| Insider sale notice | 144 | 2023-04-19 | - |
| Insider sale notice | 144 | 2023-04-19 | - |
| Insider sale notice | 144 | 2023-04-19 | - |
| Proxy statement | DEF 14A | 2023-04-13 | 2023-04-13 |
| Annual report to shareholders | ARS | 2023-04-13 | 2022-12-31 |
| Passive ownership stake | SC 13G | 2023-04-05 | - |
| PRE 14A | - | 2023-04-03 | 2023-04-03 |